Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,59 AUD | +7,27% |
|
+11,32% | +10,28% |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 01/05/12 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Thomas Jarrett
COO | Chief Operating Officer | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/12 |
Justin Ward
BRD | Director/Board Member | - | 01/01/16 |
Director/Board Member | - | 29/11/17 | |
Daniel Astudillo
SAM | Sales & Marketing | - | 01/04/18 |
Maggie Niewidok
SEC | Corporate Secretary | - | 01/09/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
John Prendergast
CHM | Chairman | 70 | 24/04/18 |
Alan Dunton
BRD | Director/Board Member | 70 | 14/07/20 |
Director/Board Member | - | 29/11/17 | |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/12 |
James Graham
CEO | Chief Executive Officer | - | 01/05/12 |
Justin Ward
BRD | Director/Board Member | - | 01/01/16 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 203 701 863 | 125 491 504 ( 61,61 %) | 0 | 61,61 % |
Coordinate società
Recce Pharmaceuticals Ltd.
Salesforce Tower 180 George Street
2000, Sydney
+61 2 9256 2505
http://www.recce.com.au![Indirizzo Recce Pharmaceuticals Ltd(RCE)](https://cdn.zonebourse.com/static/address/24446338.png)
Settore
Vendite per regione
Revisioni EPS
Utili annuali - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
+10,28% | 74,04 Mln | |
+51,82% | 797 Mrd | |
+40,72% | 628 Mrd | |
-6,88% | 351 Mrd | |
+16,95% | 323 Mrd | |
+9,49% | 300 Mrd | |
+17,08% | 244 Mrd | |
+0,90% | 223 Mrd | |
+5,30% | 163 Mrd | |
-6,29% | 153 Mrd |
- Borsa valori
- Azioni
- Azione RCE
- Società Recce Pharmaceuticals Ltd